We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Dollar General
DG
$27.1B
| $1.91M | 0.03% |
33,275
+28,840
| +650% | +$1.65M |
|
|
NPBC
402
DELISTED
NATL PENN BANCSHARES INC
NPBC
| $1.9M | 0.03% |
+179,616
| New | +$1.85M |
|
403
Trane Technologies
TT
$92.3B
| $1.88M | 0.03% |
30,012
+7,601
| +34% | +$451K |
|
|
NBL
404
DELISTED
Noble Energy, Inc.
NBL
| $1.87M | 0.03% |
+24,174
| New | +$1.76M |
|
405
Five Below
FIVE
$12.9B
| $1.86M | 0.03% |
+46,672
| New | +$1.78M |
|
|
BERY
406
DELISTED
Berry Global Group, Inc.
BERY
| $1.86M | 0.03% |
78,606
+48,441
| +161% | +$1.06M |
|
|
CVO
407
DELISTED
Cenevo, Inc.
CVO
| $1.85M | 0.03% |
+62,500
| New | +$1.58M |
|
408
Crown Holdings
CCK
$12.2B
| $1.85M | 0.03% |
37,128
+2,486
| +7% | +$119K |
|
409
Travelers Companies
TRV
$78.5B
| $1.83M | 0.03% |
+19,452
| New | +$1.77M |
|
|
K
410
DELISTED
Kellanova
K
| $1.8M | 0.03% |
29,141
+22,000
| +308% | +$1.38M |
|
|
RAI
411
DELISTED
Reynolds American Inc
RAI
| $1.8M | 0.03% |
59,504
+23,006
| +63% | +$660K |
|
|
AWAY
412
DELISTED
HOMEAWAY INC COM
AWAY
| $1.79M | 0.03% |
51,499
-241,621
| -82% | -$7.95M |
|
|
MONT
413
DELISTED
MONTAGE TECHNOLOGY GROUP LTD
MONT
| $1.79M | 0.03% |
86,572
+53,098
| +159% | +$1.06M |
|
|
SEE
414
DELISTED
Sealed Air
SEE
| $1.79M | 0.03% |
+52,379
| New | +$1.73M |
|
|
TVRD
415
Tvardi Therapeutics
TVRD
$23.2M
| $1.79M | 0.03% |
2,917
| – | – |
|
|
ODP
416
DELISTED
ODP
ODP
| $1.78M | 0.03% |
31,343
+3,676
| +13% | +$179K |
|
|
SWFT
417
DELISTED
Swift Transportation Company
SWFT
| $1.76M | 0.03% |
69,802
+61,568
| +748% | +$1.49M |
|
418
Avery Dennison
AVY
$13B
| $1.75M | 0.03% |
34,181
+30,181
| +755% | +$1.5M |
|
|
OMED
419
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.75M | 0.03% |
75,001
| – | – |
|
420
FNB Corp
FNB
$6.34B
| $1.74M | 0.03% |
135,967
-43,181
| -24% | -$544K |
|
|
VXRT
421
DELISTED
Vaxart
VXRT
| $1.71M | 0.03% |
54,545
| – | – |
|
422
Burlington
BURL
$14.5B
| $1.7M | 0.03% |
+53,316
| New | +$1.54M |
|
423
Norfolk Southern
NSC
$71.3B
| $1.69M | 0.03% |
+16,404
| New | +$1.61M |
|
424
3D Systems Corp
DDD
$518M
| $1.66M | 0.03% |
+27,805
| New | +$1.43M |
|
425
W.W. Grainger
GWW
$59.3B
| $1.64M | 0.03% |
6,464
+4,815
| +292% | +$1.23M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.